Literature DB >> 11821895

Steps toward mapping the human vasculature by phage display.

Wadih Arap1, Mikhail G Kolonin, Martin Trepel, Johanna Lahdenranta, Marina Cardó-Vila, Ricardo J Giordano, Paul J Mintz, Peter U Ardelt, Virginia J Yao, Claudia I Vidal, Limor Chen, Anne Flamm, Heli Valtanen, Lisa M Weavind, Marshall E Hicks, Raphael E Pollock, Gregory H Botz, Corazon D Bucana, Erkki Koivunen, Dolores Cahill, Patricia Troncoso, Keith A Baggerly, Rebecca D Pentz, Kim-Anh Do, Christopher J Logothetis, Renata Pasqualini.   

Abstract

The molecular diversity of receptors in human blood vessels remains largely unexplored. We developed a selection method in which peptides that home to specific vascular beds are identified after administration of a peptide library. Here we report the first in vivo screening of a peptide library in a patient. We surveyed 47,160 motifs that localized to different organs. This large-scale screening indicates that the tissue distribution of circulating peptides is nonrandom. High-throughput analysis of the motifs revealed similarities to ligands for differentially expressed cell-surface proteins, and a candidate ligand-receptor pair was validated. These data represent a step toward the construction of a molecular map of human vasculature and may have broad implications for the development of targeted therapies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821895     DOI: 10.1038/nm0202-121

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  173 in total

1.  Sugar creates a sticky business: round up the usual suspects.

Authors:  James T Rosenbaum
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 2.  New insights into endothelial diversity.

Authors:  James E Tomlinson; James N Topper
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

Review 3.  Targeting gene therapy vectors to the vascular endothelium.

Authors:  Lorraine M Work; Stuart A Nicklin; Andrew H Baker
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

4.  Genetically modified T cells targeting interleukin-11 receptor α-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases.

Authors:  Gangxiong Huang; Ling Yu; Laurence Jn Cooper; Mario Hollomon; Helen Huls; Eugenie S Kleinerman
Journal:  Cancer Res       Date:  2011-11-10       Impact factor: 12.701

5.  A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.

Authors:  Kirstin F Barnhart; Dawn R Christianson; Patrick W Hanley; Wouter H P Driessen; Bruce J Bernacky; Wallace B Baze; Sijin Wen; Mei Tian; Jingfei Ma; Mikhail G Kolonin; Pradip K Saha; Kim-Anh Do; James F Hulvat; Juri G Gelovani; Lawrence Chan; Wadih Arap; Renata Pasqualini
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

6.  Endothelial cell diversity revealed by global expression profiling.

Authors:  Jen-Tsan Chi; Howard Y Chang; Guttorm Haraldsen; Frode L Jahnsen; Olga G Troyanskaya; Dustin S Chang; Zhen Wang; Stanley G Rockson; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

Review 7.  Fishing for novel angiogenic therapies.

Authors:  Kameha R Kidd; Brant M Weinstein
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 8.  Endothelial cell heterogeneity.

Authors:  William C Aird
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 9.  Virus-Derived Peptides for Clinical Applications.

Authors:  Mingying Yang; Kegan Sunderland; Chuanbin Mao
Journal:  Chem Rev       Date:  2017-07-19       Impact factor: 60.622

10.  Prospective identification of parasitic sequences in phage display screens.

Authors:  Wadim L Matochko; S Cory Li; Sindy K Y Tang; Ratmir Derda
Journal:  Nucleic Acids Res       Date:  2013-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.